14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.317 29 days ( -28.03 % )
Last Price $5.07 -3.80 %
High/ Low $5.05 - $5.40 5.59%
Chg 7 Days -5.32 % $5.36 $5.07
Chg 30 Days 25.50 % $4.04 $5.07
Chg 12 mos 1,624.49 % $0.294 $5.07
Trend - 3 mos 37.94 % Width: 50.71 %
Trend - 12 mos 13.88 % Width: 547.20 %
Pred. range - 3 mos $6.18 - $9.31 21.85 % - 83.64 %
Pred. range - 12 mos $1.15 - $7.44 -77.32 % - 46.79 %
Short MA avg 3 mos Sell Apr 12, 2024 - 7 days
Long MA avg 3 mos Buy Mar 11, 2024 - 30 days
Short/Long MA avg 3 mos Buy Mar 13, 2024 - 28 days
Short MA avg 12 mos Sell Apr 19, 2024 - 2 days
Long MA avg 12 mos Buy Jan 09, 2024 - 72 days
Short/Long MA avg 12 mos Buy Jan 12, 2024 - 69 days
Pivot Short Sell Apr 10, 2024 - 9 days
Bollinger Buy Mar 13, 2024 - 28 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Lipocine Inc.

Lipocine. Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioident... LPCN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT